Medicaid Monitor
Policy Intelligence
Medicaid Monitor
Policy Intelligence
Updated 12:32 PM MT
© 2026 Lanphier Ventures, LLC
Informational use only. Not legal or compliance advice.
← All stories
Industry·August 19, 2026

Trump Nominates White House Health Adviser Heidi Overton as FDA Commissioner

President Trump announced Wednesday he will nominate Dr. Heidi Overton, currently a White House domestic policy adviser on health issues, to serve as FDA Commissioner. The nomination comes amid significant staff turnover at the agency. If confirmed by the Senate, Overton would lead the FDA's oversight of prescription drugs, including Medicaid drug coverage policy and pharmaceutical manufacturer rebates. The nomination's impact on Medicaid will depend on Senate confirmation timing and Overton's policy priorities once in office.

Why it matters

FDA leadership influences Medicaid drug policy through approval decisions, labeling requirements, and manufacturer accountability that affect state formularies and rebate programs.

Pharmacy

Read the full article at thehill.com

Share this briefing

You might also like

← All stories

Get the daily briefing.